Andy Ho joined Royal Philips in August 2015 as the Executive Vice President before becoming the CEO of Philips Greater China in November 2015. In July 2016, he was also appointed as a member of the Royal Philips Executive Committee.
He started with Philips during a period of unprecedented strategic transformation for the 128-year old company and has played an exceptional role in its evolution into a leading health technology solutions provider in the Greater China Market. He is passionate about business transformation, localization, entrepreneurship as well as open innovation to drive competitiveness and customer value in the Greater China market.
Andy further enhances the position of Philips as a leader of health technology in the local market by steering the company to focus on the commitment to creating value to “Healthy China 2030” as well as his team to advance the strategic transformation through the “China model’.
Key localization strategic initiatives under his direction include end-to-end business model transformation of solutions; precise segmentation of customer strategy in the professional market; addressing the top 3 chronic diseases in China, namely cardiovascular, cerebrovascular and oncological diseases, with integrated solutions across the health continuum of pre-, intra- and post-hospitalization; transformation into Direct2Consumers approach; Omni-channel as well as experiential marketing in the consumer market.
Under his leadership, Philips has become a trusted partner for professional customers and a personal health expert for individual consumers across the health continuum. China, with sustained growth and being the second largest market of Philips, has been one of the major growth engines for the global Philips.